Does non-attenuation correction influence lesion detectability in FDG PET of thyroid cancer.

被引：0
|
作者：
Helal, BO
Trebossen, R
Pointurier, I
Delbot, T
Leperse, V
Syrota, A
机构：
[1] Hop Antoine Beclere, Clamart, France
[2] CEA, Serv Hosp Frederic Joliot, F-91406 Orsay, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1284
引用
收藏
页码：319P / 319P
页数：1
相关论文
共 50 条
  • [31] Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET
    D. Visvikis
    C. Cheze-LeRest
    D. Costa
    J. Bomanji
    S. Gacinovic
    P. Ell
    European Journal of Nuclear Medicine, 2001, 28 : 1326 - 1335
  • [32] Influence of 18F-PDG-PET on treatment in patients with differentiated thyroid cancer.
    Schlyter, B
    Plotkin, M
    Klutmann, S
    Beyer, W
    Bohuslavizki, H
    Mester, J
    Clausen, M
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 234P - 234P
  • [33] Benign Schwannoma Mimicking Metastatic Lesion on F-18 FDG PET/CT in Differentiated Thyroid Cancer
    Kang S.
    Nuclear Medicine and Molecular Imaging, 2013, 47 (2) : 138 - 140
  • [34] Thyroid Incidentalomas on FDG PET/CT in Patients with Non-Thyroid Cancer - a Large Retrospective Monocentric Study
    Kim, Heeyoung
    Kim, Seong-Jang
    Kim, In-Joo
    Kim, Keunyoung
    ONKOLOGIE, 2013, 36 (05): : 260 - 264
  • [35] Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
    Yu-Chen Chang
    Tzu-Chen Yen
    Koon-Kwan Ng
    Lai-Chu See
    Chyong-Huey Lai
    Ting-Chang Chang
    Chien-Sheng Tsai
    Ji-Hong Hong
    Swei Hsueh
    Hung-Hsueh Chou
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 647 - 652
  • [36] Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
    Chang, YC
    Yen, TC
    Ng, KK
    See, LC
    Lai, CH
    Chang, TC
    Tsai, CS
    Hong, JH
    Hsueh, S
    Chou, HH
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (06) : 647 - 652
  • [37] 18F-FDG PET in the follow-up of post-therapy differentiated thyroid cancer.
    Hsu, CH
    Liu, RS
    Wu, CH
    Chen, SM
    Shih, LS
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 321P - 321P
  • [38] FDG-PET/CT may be helpful in early prediction of radioiodine-refractory differentiated thyroid cancer.
    Nakada, Kunihiro
    Kamijo, Keiichi
    Takagashi, Hiromasa
    Sugie, Hiroki
    Kato, Noriyoshi
    Sakurai, Masayuki
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [39] Does a Metallic Implant influence the CT-based attenuation correction factors in CT-PET?
    De Marco, M.
    Tesei, L.
    Bernardini, S. R.
    Maggi, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S194 - S194
  • [40] .omparison of the accuracy of 18F-FDG PET/CT and PET/MRI in attenuation correction and tumor size assessment in breast cancer
    Gelezhe, Pavel
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345